Zavante Therapeutics Alternatives & Competitors

12 companies similar to Zavante Therapeutics — A clinical-stage biopharmaceutical pioneer advancing novel therapies to enhance...

Onconova Therapeutics

Onconova is focused on discovering and developing novel products for patients with cancer.

20 Post-IPO Equity $177.92M

Newtown, United States

Biopharma Biotechnology +1

Ampio Pharmaceuticals, Inc.

7 Post-IPO Equity $75.89M

Englewood, United States

Biotechnology Health Care

ASLAN Pharmaceuticals

A clinical-stage immunology focused biopharmaceutical company.

44 IPO $218.00M

Singapore, Singapore

Biotechnology Health Care +1

Kinarus Therapeutics

Kinarus Therapeutics is a clinical-stage company developing therapies for viral, respirato...

5 Post-IPO Equity $36.55M

Basel, Switzerland

Biopharma Biotechnology +2

Track all Zavante Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Applied Therapeutics, Inc.

45 Post-IPO Equity $419.07M

New York, United States

Biotechnology Health Care +1

Antios Therapeutics

Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing th...

1 $200.40M

Atlanta, United States

Biopharma Biotechnology +1

AVEO Oncology

Committed to delivering medicines that provide a better life for patients with cancer.

197 Post-IPO Equity

Boston, United States

Biotechnology Health Care +2

Corium

Corium is a biopharmaceutical company leading the development, manufacturing, and commerci...

359 Private Equity

Boston, United States

Biopharma Health Care +1

Enalare Therapeutics Inc.

Developing novel therapies for life-threatening acute respiratory and critical care condit...

10 $22.53M

Princeton, United States

Biopharma Biotechnology +1

Allecra Therapeutics

Our Mission: Answering the call to action to fight antibiotic resistance

7 Series B $37.00M

Biopharma Biotechnology +1

Biscayne Neurotherapeutics Inc

A clinical-stage biotechnology company advancing innovative therapies for challenging neur...

2-10 Series B $3.00M

Miami, United States

Biotechnology Health Care +2

BeBetter Med

Clinical-stage drug discovery and development of advanced novel medicines for cancer and o...

5 Private Equity $499.00M

China

Health Care Pharmaceutical

About Zavante Therapeutics

Zavante Therapeutics is a clinical-stage biopharmaceutical company founded in 2015, focused on developing novel therapies to improve the outcomes of hospitalized patients. The company's slogan encapsulates its mission: "A clinical-stage biopharmaceutical pioneer advancing novel therapies to enhance the outcomes of hosp...

Taxonomy

Biopharmaceutical, Clinical-stage, Therapies, Hospitalized Patients, Novel, Pharmaceutical, Drug Development, Hospital Treatments, Clinical Trials

Frequently Asked Questions

Companies similar to Zavante Therapeutics include Onconova Therapeutics, Ampio Pharmaceuticals, Inc., ASLAN Pharmaceuticals, Kinarus Therapeutics, Applied Therapeutics, Inc.. They work in Biotechnology and Health Care and share Zavante Therapeutics's focus on clinical-stage, drug development and clinical trials.

Bounce Watch lists 12 companies that share Zavante Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Zavante Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Zavante Therapeutics Profile Onconova Therapeutics Alternatives Applied Therapeutics, Inc. Alternatives Antios Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Zavante Therapeutics on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 29 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.